| __timestamp | Pharming Group N.V. | Taro Pharmaceutical Industries Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 4167274 | 179279000 |
| Thursday, January 1, 2015 | 5247851 | 186359000 |
| Friday, January 1, 2016 | 4925118 | 171785000 |
| Sunday, January 1, 2017 | 14930297 | 208136000 |
| Monday, January 1, 2018 | 25371768 | 198405000 |
| Tuesday, January 1, 2019 | 23921274 | 224169000 |
| Wednesday, January 1, 2020 | 25338236 | 245044000 |
| Friday, January 1, 2021 | 20182966 | 252314000 |
| Saturday, January 1, 2022 | 17562000 | 268225000 |
| Sunday, January 1, 2023 | 25212000 | 304629000 |
| Monday, January 1, 2024 | 324203000 |
Igniting the spark of knowledge
In the ever-evolving pharmaceutical industry, understanding cost dynamics is crucial. Over the past decade, Pharming Group N.V. and Taro Pharmaceutical Industries Ltd. have showcased contrasting trends in their cost of revenue. From 2014 to 2023, Pharming Group N.V. saw a significant increase, with costs rising by over 500%, peaking in 2023. Meanwhile, Taro Pharmaceutical Industries Ltd. maintained a more stable trajectory, with costs increasing by approximately 70% over the same period. Notably, Taro's cost of revenue in 2023 was nearly 12 times that of Pharming, highlighting its larger scale of operations. However, data for 2024 is missing for Pharming, leaving room for speculation on its future financial strategies. This analysis underscores the importance of cost management in sustaining competitive advantage in the pharmaceutical sector.
Cost of Revenue: Key Insights for Bristol-Myers Squibb Company and Pharming Group N.V.
Cost of Revenue Trends: Neurocrine Biosciences, Inc. vs Taro Pharmaceutical Industries Ltd.
BioMarin Pharmaceutical Inc. vs Pharming Group N.V.: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: Pharming Group N.V. vs PTC Therapeutics, Inc.
Analyzing Cost of Revenue: Pharming Group N.V. and Perrigo Company plc
Cost of Revenue Comparison: Pharming Group N.V. vs Veracyte, Inc.
Cost of Revenue Trends: Pharming Group N.V. vs HUTCHMED (China) Limited
Cost of Revenue Trends: Pharming Group N.V. vs Evotec SE
Cost of Revenue Trends: Lantheus Holdings, Inc. vs Taro Pharmaceutical Industries Ltd.
Analyzing Cost of Revenue: PTC Therapeutics, Inc. and Taro Pharmaceutical Industries Ltd.
Comparing Cost of Revenue Efficiency: Supernus Pharmaceuticals, Inc. vs Taro Pharmaceutical Industries Ltd.
Cost Insights: Breaking Down Taro Pharmaceutical Industries Ltd. and Viridian Therapeutics, Inc.'s Expenses